Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Treasury Shares: 2022-2025

Historic Treasury Shares for Caribou Biosciences (CRBU) over the last 4 years, with Sep 2025 value amounting to $2.2 million.

  • Caribou Biosciences' Treasury Shares rose 71.14% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 71.14%. This contributed to the annual value of $1.3 million for FY2024, which is 531.74% up from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Treasury Shares is $2.2 million, which was up 32.37% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Caribou Biosciences' Treasury Shares peaked at $2.2 million during Q3 2025, and registered a low of $60,000 during Q1 2022.
  • Its 3-year average for Treasury Shares is $1.1 million, with a median of $1.3 million in 2024.
  • Its Treasury Shares has fluctuated over the past 5 years, first crashed by 35.16% in 2023, then skyrocketed by 673.49% in 2024.
  • Over the past 4 years, Caribou Biosciences' Treasury Shares (Quarterly) stood at $256,146 in 2022, then decreased by 19.83% to $205,357 in 2023, then spiked by 531.74% to $1.3 million in 2024, then spiked by 71.14% to $2.2 million in 2025.
  • Its Treasury Shares stands at $2.2 million for Q3 2025, versus $1.7 million for Q2 2025 and $2.2 million for Q1 2025.